KCNH2 and channelopathy: Proof-of-concept studies in LQTS models, particularly for KCNH2 (LQT2), have demonstrated that antisense oligonucleotides can modulate splicing and increase functional channel expression, drawing on lessons from cystic fibrosis and other channelopathies.